GGrantIndex
← Search

IGF::OT::IGF The development leading to the commercialization of a bioresorbable stents (BRS) for the treatment of coarctation of the aorta (COA) in neonates.

$397,952N43FY2016HLNIH

Pediastent Llc, Chagrin Falls OH

Investigators

Tim Morancontact

Abstract

DEVELOPMENT LEADING TO THE COMMERCIALIZATION OF A BIORESORBABLE STENTS (BRS) FOR THE TREATMENT OF COARCTATION OF THE AORTA (COA) IN NEONATES.

View original record on NIH RePORTER →
IGF::OT::IGF The development leading to the commercialization of a bioresorbable stents (BRS) for the treatment of coarctation of the aorta (COA) in neonates. · GrantIndex